# Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

> clinical trial · VERIFIED · 2026-06-23

Status: RECRUITING · Sponsor: Merck Sharp & Dohme LLC · Condition: Gastrointestinal Cancer

- Company: Merck Sharp & Dohme LLC
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT06596694

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.